Location: NEW YORK, NY
CIK: 0001633313 · Show all filings
Period: Q4 2020 (← Previous) (Next →)
Filing Date: Feb 16, 2021
Total Value ($000): $5,806,523 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | MIRATI THERAPEUTICS INC | 4,535,000 | $996,067 | 17.2% | $38.71 | — | Common | 60468T105 |
| — | HORIZON THERAPEUTICS PLC | 9,000,000 | $658,350 | 11.3% | $46.60 | — | Common | G46188101 |
| UTHR | UNITED THERAPEUTICS CORP | 2,850,000 | $432,602 | 7.5% | $131.23 | 0.0% | Common | 91307C102 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 7,500,000 | $348,000 | 6.0% | $13.29 | +198.8% | Common | 462260100 |
| — | ARENA PHARMACEUTICALS INC | 4,190,000 | $321,918 | 5.5% | $72.64 | — | Common | 040047607 |
| ASND | ASCENDIS PHARMA | 1,800,000 | $300,204 | 5.2% | $45.84 | — | Sponsored ADR | 04351P101 |
| SRPT | SAREPTA THERAPEUTICS INC | 1,750,000 | $298,358 | 5.1% | $110.24 | +34.4% | Common | 803607100 |
| ARGX | ARGENX SE | 902,500 | $265,416 | 4.6% | $67.74 | — | Sponsored ADR | 04016X101 |
| FOLD | AMICUS THERAPEUTICS INC | 9,000,000 | $207,810 | 3.6% | $10.45 | +95.6% | Common | 03152W109 |
| — | ACCELERON PHARMA INC | 1,550,000 | $198,307 | 3.4% | $99.94 | — | Common | 00434H108 |
| — | MERSANA THERAPEUTICS INC | 6,800,000 | $180,948 | 3.1% | $23.19 | — | Common | 59045L106 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 1,650,000 | $144,689 | 2.5% | $84.64 | -6.3% | Common | 09061G101 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 1,225,000 | $136,183 | 2.3% | $125.28 | -2.4% | Common | 558868105 |
| KURA | KURA ONCOLOGY INC | 4,000,000 | $130,640 | 2.2% | $25.18 | +39.6% | Common | 50127T109 |
| PMVP | PMV PHARMACEUTICALS INC | 2,350,267 | $130,536 | 2.2% | $37.32 | +5.1% | Common | 69353Y103 |
| ACAD | ACADIA PHARMACEUTICALS INC | 1,950,000 | $104,247 | 1.8% | $49.64 | 0.0% | Common | 004225108 |
| — | ADVERUM BIOTECHNOLOGIES INC | 8,000,000 | $86,720 | 1.5% | $11.14 | — | Common | 00773U108 |
| — | TRILLIUM THERAPEUTICS INC | 5,800,000 | $85,318 | 1.5% | $5.91 | — | Common | 89620X506 |
| — | CONSTELLATION PHARMACEUTICALS INC | 2,950,000 | $84,960 | 1.5% | $43.99 | — | Common | 210373106 |
| — | DECIPHERA PHARMACEUTICALS INC | 1,300,000 | $74,191 | 1.3% | $46.44 | — | Common | 24344T101 |
| — | PRAXIS PRECISION MEDICINES INC | 1,545,495 | $68,709 | 1.2% | $44.46 | — | Common | 74006W108 |
| — | CYMABAY THERAPEUTICS INC | 10,300,000 | $59,122 | 1.0% | $6.26 | — | Common | 23257D103 |
| — | IVERIC BIO INC | 7,250,000 | $50,098 | 0.9% | $5.11 | — | Common | 46583P102 |
| TVTX | TRAVERE THERAPEUTICS INC | 1,800,500 | $49,073 | 0.8% | $23.35 | 0.0% | Common | 89422G107 |
| RLMD | RELMADA THERAPEUTICS INC | 1,525,000 | $48,907 | 0.8% | $40.49 | -15.1% | Common | 75955J402 |
| XENE | XENON PHARMACEUTICALS INC | 2,800,000 | $43,064 | 0.7% | $9.61 | +21.7% | Common | 98420N105 |
| — | MARINUS PHARMACEUTICALS INC | 3,232,142 | $39,432 | 0.7% | $12.20 | — | Common | 56854Q200 |
| OLMA | OLEMA PHARMACEUTICALS INC | 876,986 | $35,646 | 0.6% | $46.89 | 0.0% | Common | 68062P106 |
| — | AMARIN CORP PLC | 6,000,000 | $29,340 | 0.5% | $8.22 | — | Sponsored ADR | 023111206 |
| — | AVADEL PHARMACEUTICALS PLC | 4,365,000 | $29,158 | 0.5% | $7.90 | — | Sponsored ADR | 05337M104 |
| RLAY | RELAY THERAPEUTICS INC | 500,000 | $20,780 | 0.4% | $38.13 | +18.6% | Common | 75943R102 |
| BDTX | BLACK DIAMOND THERAPEUTICS INC | 640,000 | $20,512 | 0.4% | $30.40 | +8.1% | Common | 09203E105 |
| ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | 3,550,000 | $19,135 | 0.3% | $9.83 | — | Sponsored ADR | 00653A107 |
| — | ITEOS THERAPEUTICS INC | 460,000 | $15,557 | 0.3% | $24.67 | — | Common | 46565G104 |
| — | THERAPEUTICS ACQUISITION CORP | 1,000,000 | $13,950 | 0.2% | $14.38 | — | Common | 88339T103 |
| RNAM | AVIDITY BIOSCIENCES INC | 545,000 | $13,908 | 0.2% | $28.83 | +1.1% | Common | 05370A108 |
| FENC | FENNEC PHARMACEUTICALS INC | 1,670,000 | $12,442 | 0.2% | $9.85 | -22.7% | Common | 31447P100 |
| GNCAQ | GENOCEA BIOSCIENCES INC | 5,084,184 | $12,304 | 0.2% | $2.62 | -13.2% | Common | 372427401 |
| MNKD | MANNKIND CORP | 3,500,000 | $10,955 | 0.2% | $2.62 | 0.0% | Common | 56400P706 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 450,000 | $10,008 | 0.2% | $20.74 | 0.0% | Common | 87164F105 |
| — | BCTG ACQUISITION CORP | 800,000 | $9,152 | 0.2% | $10.84 | — | Common | 05492W103 |
| CUE | CUE BIOPHARMA INC | 452,500 | $5,661 | 0.1% | $10.47 | +27.2% | Common | 22978P106 |
| — | ATHENEX INC | 372,500 | $4,120 | 0.1% | $18.13 | — | Common | 04685N103 |
| — | NEKTAR THERAPEUTICS | 100,000 | $26 | 0.0% | — | — | Call | 640268108 |